US Market Report for Vaginal Slings 2017 – MedCore

US Market Report for Vaginal Slings 2017 – MedCore

0

Vaginal slings or urinary incontinence slings are medical devices placed under the urethra through a small incision to treat incontinence symptoms. Stress urinary incontinence (SUI) can be classified in three forms: intrinsic sphincter deficiency (ISD), urethral hypermobility or male loss of internal and external sphincter functionality. Slings are commonly used in women who have urethral hypermobility. A sling will stop the hypermobility, but the patient may still have stress urinary incontinence due to an intrinsic sphincter deficiency (ISD). ISD occurs when the urethral sphincter is unable to generate enough resting pressure to prevent urine from seeping out. Urethral hypermobility, also known as Type II SUI, is due to weakened anatomic urethral support, often caused by childbearing. Male loss of sphincter functionality is relatively rare. Vaginal slings directly compete with bulking agents; however, slings are considered the leading technology for treating SUI.

  • Year: 2017
  • Scope: 2013-2023
  • Region: United States
  • Published Date: 7/1/2017
  • Pages: 527
  • Type: MedCore

General Report Contents
– Market Analyses include: Unit Sales, ASPs, Market Value & Growth Trends
– Market Drivers & Limiters for each chapter segment
– Competitive Analysis for each chapter segment
– Section on recent mergers & acquisitions
The total market for vaginal slings includes biologic and synthetic slings. While synthetic slings constitute the majority of this market, ongoing scrutiny by the FDA specifically towards synthetic slings has had a substantial negative impact on the vaginal sling market as a whole. As advertisements of the FDA concerns relating to the increased incidences of erosion after the implantation of synthetic slings increases, patients will become more reluctant to go forward with the procedure. The repercussions of this impact will extend throughout most of the forecast period before the market slowly begins to rebound.
Synthetic slings have been the standard device used for the surgical treatment of urinary incontinence for several years but unit sales are expected to continue to decrease in response to the FDA warnings before partially recovering later in the forecast period. This segment was followed by biologic slings, which occupied a small portion of the vaginal sling market. This segment was somewhat adversely affected by the FDA warnings due to the media’s negative portrayal of all vaginal slings, which led to a general negative stigma harbored by the public towards both synthetic and biologic vaginal slings. However, surgeons are aware that the biologic slings do not result in the same complications that have been associated with the synthetic slings, and will likely support the use of these biologic devices. This will benefit the biologic slings and promote continued growth of this segment.
In the next few years, the biologic market will continue to grow at a faster pace than the synthetic market, however this trend will reverse itself by 2020. Most vaginal sling implantation procedures are performed on an in-patient basis; however, recently the trend has been moving towards out-patient surgery. This trend is due to the gaining popularity of single-incision slings and other easier to install versions of traditional vaginal sling devices that reduce the degree of invasiveness of the implantation procedure, often allowing for the surgery to be conducted in an out-patient setting.



The "US Market Report Suite for Soft Tissue Reinforcement and Regeneration 2017 - MedSuite" includes analysis on the following companies currently active in this market:
LifeCell
Organogenesis
C.R. Bard
Ethicon
Covidien
Arthrex
ASTORA
Wright Medical
Integra LifeSciences
Smith & Nephew
MiMedx
Boston Scientific
Systagenix
BioHorizons
Atrium Medical
Coloplast
Stryker
Cook Medical
Johnson & Johnson
Osiris
Soluble Systems
Synovis/Baxter
KCI
RTI Biologics
Geistlich
TEI
Zimmer Biomet
ACell
Aesculap/B. Braun
Gore Medical
Medtronic
Dentsply
Others include: Medline, MTF, WL Gore, Tutogen, Novus Scientific, Ariste Medical
*Not all companies are currently active in every segment or sub-report from this suite. For more details contact an iData Research Product Advisor.




Our reports follow an in-depth 9-step methodology which focuses on the following research systems:

  • Original primary research that consists of the most up-to-date market data
  • Strong foundation of quantitative and qualitative research
  • Focused on the needs and strategic challenges of the industry participants

Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.

Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.

Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.

Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.

Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.

Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.

Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.

Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.

Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.

Click Here to Read More About Our Methodology

Not Exactly What You Need?
close-link
close-link
close-link

Subscribe to MedTech Market News - Get exclusive analyst articles, monthly newsletters and iData offers

close-link
close-link
close-link
close-link